I was recently interviewed for an article by Kevin Davies at Bio-IT World on our GenomeQuest 6.0Beta launch. He immediately connected our story to “NGS” and “Cloud” computing. We have deliberately not over-played the “cloud” aspect of our offering, but as the response from the article shows, there is a lot of interest in the potential economics of the cloud and customer are actively evaluating its potential.
From my view, cloud vendors such as Amazon and others will follow the commodity pricing curve of the instruments and become a way to process larger and larger data sets with fewer and fewer dollars. For us, cloud computing is an opportunity to offer more customers more services at lower costs. However, the winning strategy will require value added software, knowledge and skills to harness those resources for organizations and their end-users.
More on this topic in a future post.
